Echelon Biosciences Inc.

Salt Lake City, UT Part of Frontier Scientific, Inc.

UEI
EDK8FFD24SC4
CAGE
46MB5
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
675 Arapeen Dr #302, Salt Lake City, UT 84108, USA
Website
echelon-inc.com
Founded
1997
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Echelon Biosciences Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Custom synthesis of two materials, proposed and approved as an innovation fund project. 13C- hydroxy-IP 85MG… Contract · 12905B22P0081 Pacific West Area $11,070
Army sbir phase i Contract · W911QY20P0034 ACC Aberdeen Proving Ground $167,500
Accessible and robust tools for glycosaminoglycan profiling Grant · R43GM131444 National Institute of General Medical Sciences $300,000
Transgenic black soldier flies for sustainable, improved nutrition sbir 16.3 phase II Contract · 140D6318C0031 Interior Business Center $1,496,661
"transgenic black soldier flies for sustainable, improved nutrition" Contract · IND17PC00157 Interior Business Center $149,592

About Echelon Biosciences Inc.

Echelon Biosciences Inc. is a global leader in biochemical reagents, assays, and peptides for academic research and pharmaceutical development. The company specializes in custom synthesis and assay development, providing tools and reagents for life science research. It is a for-profit organization that manufactures goods and has been registered in SAM.gov since 2005.

Through federal contract awards, Echelon Biosciences Inc. has provided custom synthesis of materials to the Department of Agriculture Agricultural Research Service. In one instance, it synthesized two materials under an innovation fund project, delivering 13C-hydroxy-IP and 13C-aniline-IPP through a $11,070 purchase order contract. Additionally, the company received a $167,499.96 purchase order contract from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense. This contract was awarded under the Army SBIR (Small Business Innovation Research) Phase I program and set aside for a total small business.

Echelon Biosciences Inc. has also participated in federal grant awards as a sub-awardee. It received a sub-grant from the University of Rochester for a project titled "Neuroprotectant therapeutic interventions to prevent neurological consequences in combat causalities." No further details about the goods or services provided through this grant were available in the provided information.

Quick answers

What is Echelon Biosciences Inc.'s UEI?

Echelon Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is EDK8FFD24SC4.

What is Echelon Biosciences Inc.'s CAGE code?

Echelon Biosciences Inc.'s CAGE code is 46MB5.

What is Echelon Biosciences Inc.'s primary NAICS code?

Echelon Biosciences Inc.'s primary NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).

Where is Echelon Biosciences Inc. located?

Echelon Biosciences Inc.'s physical address in SAM.gov is 675 Arapeen Dr #302, Salt Lake City, UT 84108, USA.

Is Echelon Biosciences Inc. registered in SAM.gov?

Echelon Biosciences Inc.'s SAM.gov registration expired on June 27, 2026.

Who is Echelon Biosciences Inc.'s parent company?

Echelon Biosciences Inc. is part of Frontier Scientific, Inc.

What is Echelon Biosciences Inc.'s most recent federal award?

Echelon Biosciences Inc.'s most recent federal contract award is Custom synthesis of two materials, proposed and approved as an innovation fund project. 13C- hydroxy-IP 85MG… (12905B22P0081), from Pacific West Area, on March 3, 2022.

On GovTribe

See Echelon Biosciences Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors